JP2004538285A5 - - Google Patents

Download PDF

Info

Publication number
JP2004538285A5
JP2004538285A5 JP2003513957A JP2003513957A JP2004538285A5 JP 2004538285 A5 JP2004538285 A5 JP 2004538285A5 JP 2003513957 A JP2003513957 A JP 2003513957A JP 2003513957 A JP2003513957 A JP 2003513957A JP 2004538285 A5 JP2004538285 A5 JP 2004538285A5
Authority
JP
Japan
Prior art keywords
thiazolidin
phenyl
piperidinylethyl
compound
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003513957A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004538285A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/022367 external-priority patent/WO2003008398A1/en
Publication of JP2004538285A publication Critical patent/JP2004538285A/ja
Publication of JP2004538285A5 publication Critical patent/JP2004538285A5/ja
Withdrawn legal-status Critical Current

Links

JP2003513957A 2001-07-16 2002-07-16 アリール置換チアゾリジノンおよびその使用 Withdrawn JP2004538285A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30509901P 2001-07-16 2001-07-16
PCT/US2002/022367 WO2003008398A1 (en) 2001-07-16 2002-07-16 Aryl substituted thiazolidinones and the use thereof

Publications (2)

Publication Number Publication Date
JP2004538285A JP2004538285A (ja) 2004-12-24
JP2004538285A5 true JP2004538285A5 (enExample) 2005-09-22

Family

ID=23179332

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003513957A Withdrawn JP2004538285A (ja) 2001-07-16 2002-07-16 アリール置換チアゾリジノンおよびその使用

Country Status (7)

Country Link
US (2) US7169782B2 (enExample)
EP (1) EP1417187A1 (enExample)
JP (1) JP2004538285A (enExample)
CA (1) CA2453633A1 (enExample)
IL (1) IL159765A0 (enExample)
MX (1) MXPA04000411A (enExample)
WO (1) WO2003008398A1 (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003008398A1 (en) * 2001-07-16 2003-01-30 Euro-Celtique S.A. Aryl substituted thiazolidinones and the use thereof
ATE434610T1 (de) * 2002-03-13 2009-07-15 Euro Celtique Sa Aryl substituierte pyrimidine und deren verwendung
CN1671672A (zh) * 2002-07-31 2005-09-21 欧洲凯尔特股份有限公司 芳基取代的苯并咪唑类及其作为钠通道阻滞剂的用途
US20040152696A1 (en) * 2002-08-01 2004-08-05 Euro-Celtique S.A. 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers
US20050227974A9 (en) * 2002-08-01 2005-10-13 Euro-Celtique S.A. Aminoalkyl-substituted aryl compounds and their use as sodium channel blockers
WO2004017966A1 (en) * 2002-08-23 2004-03-04 Ionix Pharmaceuticals Limited Five-membered heterocyclic compounds in the treatment of chronic and acute pain
US20120088759A1 (en) * 2009-05-12 2012-04-12 Hamed Aissaoui Thiazolidin-4-one and [1,3]-thiazinan-4-one compounds as orexin receptor antagonists
WO2012007836A1 (en) 2010-07-16 2012-01-19 Purdue Pharma .Lp. Pyridine compounds as sodium channel blockers
MX2013003101A (es) 2010-09-17 2013-09-26 Purdue Pharma Lp Compuestos de piridina y sus usos.
BR112013008374A2 (pt) 2010-10-05 2016-06-14 Purdue Pharma Lp composto de quinazolina como bloqueador do canal de sódio
EP2655330B1 (en) 2010-12-22 2016-02-10 Purdue Pharma LP Substituted pyridines as sodium channel blockers
JP5941546B2 (ja) 2011-09-02 2016-06-29 パーデュー、ファーマ、リミテッド、パートナーシップ ナトリウムチャネル遮断剤としてのピリミジン
AU2012324010A1 (en) 2011-10-31 2013-05-16 Purdue Pharma L.P. Heteroaryl compounds as sodium channel blockers
AU2012321111A1 (en) 2011-10-31 2013-05-16 Purdue Pharma L.P. Quaternized amines as sodium channel blockers
WO2013072758A1 (en) 2011-11-15 2013-05-23 Purdue Pharma L.P. Pyrimidine diol amides as sodium channel blockers
CN103130793B (zh) * 2011-11-30 2016-09-21 中国人民解放军军事医学科学院毒物药物研究所 3-(1-芳基哌啶-4-基)-2-芳基噻唑啉-4-酮类化合物、其制备方法及用途
AU2013203824A1 (en) 2012-03-16 2013-10-03 Purdue Pharma L.P. Substituted pyridines and pryimidines as sodium channel blockers
US9714252B2 (en) 2012-12-20 2017-07-25 Purdue Pharma L.P. Cyclic sulfonamides as sodium channel blockers
US9120786B2 (en) 2013-03-04 2015-09-01 Purdue Pharma, L.P. Triazine carboxamides as sodium channel blockers
ES2859148T3 (es) 2013-03-04 2021-10-01 Purdue Pharma Lp Carboxamidas de pirimidina como bloqueantes de los canales de sodio
CA3082427A1 (en) 2013-03-15 2014-09-25 Purdue Pharma L.P. Carboxamide derivatives and use thereof
US9359330B2 (en) 2013-08-26 2016-06-07 Purdue Pharma L.P. Substituted piperidines as sodium channel blockers
CN105612152A (zh) 2013-08-26 2016-05-25 普渡制药公司 氮杂螺[4.5]癸烷衍生物及其用途
US9828348B2 (en) 2013-11-08 2017-11-28 Purdue Pharma L.P. Benzimidazole derivatives and use thereof
US9340504B2 (en) 2013-11-21 2016-05-17 Purdue Pharma L.P. Pyridine and piperidine derivatives as novel sodium channel blockers
US9745287B2 (en) 2013-12-20 2017-08-29 Purdue Pharma L.P. Pyrimidines and use thereof
US9695144B2 (en) 2013-12-23 2017-07-04 Purdue Pharma L.P. Dibenzazepine derivatives and use thereof
WO2015099841A1 (en) 2013-12-23 2015-07-02 Purdue Pharma L.P. Indazoles and use thereof
EP3089978B1 (en) 2013-12-30 2018-08-29 Purdue Pharma L.P. Pyridone-sulfone morphinan analogs as opioid receptor ligands
WO2015112801A1 (en) 2014-01-24 2015-07-30 Purdue Pharma L.P. Pyridines and pyrimidines and use thereof
US10738026B2 (en) 2014-02-12 2020-08-11 Purdue Pharma L.P. Isoquinoline derivatives and use thereof
US10730866B2 (en) 2014-04-07 2020-08-04 Purdue Pharma L.P. Indole derivatives and use thereof
MA39956A (fr) 2014-05-06 2015-11-12 Purdue Pharma Lp Analogues du benzomorphane et leur utilisation
JP6360915B2 (ja) 2014-06-13 2018-07-18 パーデュー、ファーマ、リミテッド、パートナーシップ アザモルフィナン誘導体及びその使用
WO2015192039A1 (en) 2014-06-13 2015-12-17 Purdue Pharma L.P. Heterocyclic morphinan derivatives and use thereof
CA2977367A1 (en) 2015-02-19 2016-08-25 Purdue Pharma L.P. Methods and compositions for decreasing gastric emptying
CN117050031A (zh) * 2023-07-26 2023-11-14 扬州大学 氟代噻唑烷酮及其合成方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US40025A (en) * 1863-09-22 Improvement in wheel-vehicles
US55088A (en) * 1866-05-29 Improved buckle
US6947A (en) * 1849-12-11 Self-acting car-coupling
US3309377A (en) * 1964-10-19 1967-03-14 Sterling Drug Inc 3-[(2-oxazolidinone-3-yl)-alkyl]-4-thiazolidinones and their preparation
US3377355A (en) * 1967-06-30 1968-04-09 Sterling Drug Inc 4-thiazolidones and oxide derivatives thereof
CH548411A (de) 1971-12-06 1974-04-30 Ciba Geigy Ag Verfahren zur herstellung von neuen 1,1-dioxothiazolidin4-onen.
JPS5764685A (en) * 1980-10-09 1982-04-19 Kureha Chem Ind Co Ltd 2-(substituted phenyl)-1,3-thiazin-4(3,5,6h)-one and remedy for peptic ulcer containing said compound as active component
US4992455A (en) 1987-05-22 1991-02-12 Sumitomo Pharmaceuticals Company, Limited Thiazolidin-4-one derivatives useful for treating diseases caused by platelet activating factor
DE3875073T2 (de) * 1987-11-20 1993-03-11 Hoechst Roussel Pharma 3-(4(1-substituierte-4-piperazinyl)butyl)-4-thiazolidinone, verfahren zu deren herstellung und ihre anwendung als arzneimittel.
US5061720A (en) * 1989-09-13 1991-10-29 A. H. Robins Company, Inc. Substituted-4-thiazolidinone derivatives
ATE158789T1 (de) 1991-07-23 1997-10-15 Schering Corp Substituierte beta-lactam-verbindungen als hypocholesterolemische mittel und verfahren zu deren herstellung
PL176687B1 (pl) 1993-06-23 1999-07-30 Chugai Pharmaceutical Co Ltd Nowe związki, pochodne benzenu
CA2157348A1 (en) 1994-09-01 1996-03-02 Aventis Pharmaceuticals Inc. 3-¬4-(1-substituted-4-piperazinyl)butyl|-4-thiazolidinone and related compounds
EP1082315A1 (en) 1998-06-05 2001-03-14 Icagen, Inc. Potassium channel inhibitors
KR20020015308A (ko) * 1999-03-26 2002-02-27 추후보정 아릴 치환된 피라졸, 이미다졸, 옥사졸, 티아졸 및 피롤,및 이의 용도
AU4249700A (en) 1999-04-19 2000-11-02 Sumitomo Pharmaceuticals Company, Limited Hydroxamic acid derivative
AR029489A1 (es) * 2000-03-10 2003-07-02 Euro Celtique Sa Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
BR0108819A (pt) * 2000-03-24 2002-12-10 Euro Celtique Sa Pirazóis triazóis e tetrazóis substituìdos de arila, e o uso dos mesmos
IL151952A0 (en) * 2000-03-31 2003-04-10 Euro Celtique Sa Aminopyridine derivatives and pharmaceutical compositions containing the same
WO2003008398A1 (en) * 2001-07-16 2003-01-30 Euro-Celtique S.A. Aryl substituted thiazolidinones and the use thereof
AR037233A1 (es) * 2001-09-07 2004-11-03 Euro Celtique Sa Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
AR036873A1 (es) * 2001-09-07 2004-10-13 Euro Celtique Sa Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento
ATE434610T1 (de) * 2002-03-13 2009-07-15 Euro Celtique Sa Aryl substituierte pyrimidine und deren verwendung

Similar Documents

Publication Publication Date Title
JP2004538285A5 (enExample)
ES2227517T3 (es) Derivados de imidazol y su uso como inhibidores de citoquinas.
DE69322254T2 (de) Pyridyl-substituierte imidazole
JP2002533326A5 (enExample)
JPH11193281A (ja) アデノシンａ３受容体拮抗剤およびチアゾール化合物
NZ601794A (en) Di - substituted pyridine derivatives as anticancers
JP2007502806A5 (enExample)
JP2007523910A5 (enExample)
RU2003129502A (ru) Соединение, фармацевтическая композиция, применение, способ предупреждения или лечения заболеваний
JP2007536224A5 (enExample)
JP2011504485A5 (enExample)
JP2004520292A5 (enExample)
JP2008505874A5 (enExample)
JP2012506852A5 (enExample)
JP2004523535A5 (enExample)
JP2007502265A5 (enExample)
JP2008516968A5 (enExample)
JP2008512470A5 (enExample)
JP5161873B2 (ja) （２ｒ）−２−［（４−スルホニル）アミノフェニル］プロパンアミド類と、それらを含有する医薬組成物
JP2007515467A5 (enExample)
JP2005510457A5 (enExample)
CN1215392A (zh) 组胺h3受体配体
JP2022058610A5 (enExample)
US20050009785A1 (en) Heterocyclic compounds
JP2005508292A5 (enExample)